1. Introduction
===============

Previous studies on the chemical constituents from the octocorals belonging to the genus *Carijoa* (=*Telesto*) have yielded a series of bioactive substances including amide \[[@b1-marinedrugs-08-02014]\], steroid \[[@b1-marinedrugs-08-02014]--[@b4-marinedrugs-08-02014]\], and prostanoid analogs \[[@b3-marinedrugs-08-02014],[@b5-marinedrugs-08-02014]\]. In our continuing studies on the chemical constituents of octocorals distributed in Taiwan waters, a new sterol glycoside, carijoside A (**1**) ([Figure 1](#f1-marinedrugs-08-02014){ref-type="fig"}) was isolated from an octocoral identified as *Carijoa* sp. The structure of **1** was determined by spectroscopic methods and by comparison of spectral data with those of known sterols. In this paper, we describe the isolation, structure determination, and bioactivity of glycoside **1**.

2. Results and Discussion
=========================

Carijoside A (**1**) was isolated as a white powder. The molecular formula of **1** was established as C~38~H~62~O~11~ (eight degrees of unsaturation) from a sodiated molecule at *m/z* 717 in ESIMS and further supported by HRESIMS (*m/z* 717.4186, calcd. 717.4190, \[C~38~H~62~O~11~Na\]^+^). The IR spectrum of **1** showed bands at 3466 and 1743 cm^−1^, consistent with the presence of hydroxy and ester carbonyl groups. Analysis of 2D NMR experiments revealed that carijoside A (**1**) was a pentose glycoside derivative of a known trihydroxy sterol, cholestane-3*β*,5*α*,6*β*-tetrol-26-acetate (=25*ξ*-cholestane-3*β*,5*α*,6*β*,26-tetrol-26-acetate) (**2**), a cytotoxic steroid previously isolated from *Telesto riisei*, collected from Northeast Pass, Chuuk, Federated States of Micronesia \[[@b1-marinedrugs-08-02014]\] and Mangaratiba, Rio de Janeiro State, Brazil \[[@b4-marinedrugs-08-02014]\]. In addition to the pentose moiety, the ^13^C NMR and DEPT spectra of **1** showed that this compound has 29 carbons for the cholestane carbon with an acetoxy group ([Table 1](#t1-marinedrugs-08-02014){ref-type="table"}), including five methyls, 12 *sp*^3^ methylenes, eight *sp*^3^ methines, three *sp*^3^ quaternary carbons, and an *sp*^2^ quaternary carbon. From the ^13^C and ^1^H NMR spectra ([Table 1](#t1-marinedrugs-08-02014){ref-type="table"}), the presence of four oxygenated C atoms at *δ*~C~ 74.9 (d, CH-3), 75.9 (s, C-5), 76.0 (d, CH-6), and 69.6 (t, CH~2~-26) in the ^13^C NMR spectrum and two oxymethine protons at *δ*~H~ 4.07 (1H, m, H-3) and 3.54 (1H, br s, H-6) and a pair of oxygen-bearing methylene protons at *δ*~H~ 3.84 (1H, m) and 3.97 (1H, m) in the ^1^H NMR spectrum were determined. From the ^1^H-^1^H COSY spectrum, several different structural units, including C-1/-2/-3/-4, C-6/-7/-8/-9/-11/-12, C-8/-14/-15/-16/-17/-20/-22/-23/-24/-25/-26(-27), and C-20/-21, were identified ([Figure 2](#f2-marinedrugs-08-02014){ref-type="fig"}), which were assembled with the assistance of an HMBC experiment permitted elucidation of the cholestane carbon skeleton of **1**. The ring junctions C-18 and C-19 methyl groups were positioned at C-13 and C-10 from the HMBC correlations between H~3~-18/C-12, -13, -14, -17 and H~3~-19/C-1, -5, -9, -10, respectively ([Figure 2](#f2-marinedrugs-08-02014){ref-type="fig"}). An oxymethine unit at *δ*~C~ 76.0 correlated to the methine proton at *δ*~H~ 3.54 in the HMQC spectrum, proving the attachment of a hydroxy group at C-6. The remaining hydroxy and acetoxy groups at C-5 and C-26 in the cholestane moiety of **1** were indicated by analysis of HMBC correlations and characteristic NMR signals. However, the doubling of the 26-acetoxymethylene and H~3~-27 signals indicate that **1** consists of a stereoisomeric mixture (25*R*/25*S*).

Furthermore, the proton NMR signals for the pentose pyranoside between *δ*~H~ 3.6--5.3 and by the corresponding ^13^C NMR signals between *δ*~C~ 60--71 and for the characteristic sugar anomeric carbon (*δ*~C~ 97.4) and its corresponding methine proton (*δ*~H~ 5.06) ([Tables 1](#t1-marinedrugs-08-02014){ref-type="table"} and [2](#t2-marinedrugs-08-02014){ref-type="table"}). ^1^H NMR coupling constant analysis of the pyranose ring indicated the presence of a pyranoarabinoside sugar linked to the sterol by a *β*-glycoside linkage. The attachment of the sugar moiety at C-3 in **1** was based on the key HMBC correlations ([Figure 2](#f2-marinedrugs-08-02014){ref-type="fig"}). The sugar anomeric carbon C-1*′* (*δ*~C~ 97.4) and the aglycon carbon C-3 (*δ*~C~ 74.9) showed correlations with H-3 (*δ*~H~ 4.07) and H-1*′* (*δ*~H~ 5.06), respectively. NMR data also indicated the presence of two additional acetate esters positioned at C-3*′* (*δ*~H~ 5.13, 1H, dd, *J* = 10.4, 3.2 Hz; *δ*~C~ 70.5, CH) and C-4*′* (*δ*~H~ 5.25, 1H, br s; *δ*~C~ 69.4, CH). Based on detailed analysis, the structure of **1** was found to be similar with those of two known cytotoxic sterol glycosides, riisein A (3*β*-*O*-(3*′*-*O*-acetyl-*β*-[d]{.smallcaps}-arabinopyranosyl)- 25*ξ*-cholestane-3*β*,5*α*,6*β*,26-tetrol-26-acetate) (**3**) and riisein B (3*β*-*O*-(4*′*-*O*-acetyl-*β*-[d]{.smallcaps}-arabinopyranosyl)-25*ξ*-cholestane-3*β*,5*α*,6*β*,26-tetrol-26-acetate) (**4**) \[[@b4-marinedrugs-08-02014]\], with the exception that the 4*′*-hydroxy group in **3** and 3*′*-hydoxy group in **4** was replaced by an acetoxy group in **1**.

In anti-inflammatory activity testing, glycoside **1** displayed significant inhibitory effects on superoxide anion generation (IC~50~ = 1.8 μg/mL) and elastase release (IC~50~ = 6.8 μg/mL) by human neutrophils \[[@b6-marinedrugs-08-02014],[@b7-marinedrugs-08-02014]\] and this compound exhibited moderate cytotoxicity towards DLD-1 (human colon adenocarcinoma), P388D1 (murine macrophage cells), HL-60 (human premyelocytic leukemia), and CCRF-CEM (human T-cell acute lymphoblastic leukemia) tumor cells (ED~50~ = 9.7, 10.4, 12.0, and 13.1 μg/mL), respectively \[[@b8-marinedrugs-08-02014]\].

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Melting points were measured on a FARGO apparatus and were uncorrected. Optical rotation values were measured with a JASCO P-1010 digital polarimeter. The Infrared spectra were obtained on a VARIAN DIGLAB FTS 1000 FT-IR spectrophotometer. The NMR spectra were recorded on a VARIAN MERCURY PLUS 400 FT-NMR at 400 MHz for ^1^H and 100 MHz for ^13^C, in CDCl~3~, respectively, Proton chemical shifts were referenced to the residual CHCl~3~ signal (*δ*~H~ 7.26 ppm). ^13^C NMR spectra were referenced to the center peak of CDCl~3~ at *δ*~C~ 77.1 ppm. ESIMS and HRESIMS data were recorded on a BRUKER APEX II mass spectrometer. Gravity column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.2 mm, Merck) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating.

3.2. Animal Material
--------------------

Specimen of the octocoral *Carijoa* sp. were collected off the coast of Pingtung county, Southern Taiwan, in August 2008, and this organism was identified by comparison with previous descriptions \[[@b9-marinedrugs-08-02014]\]. The voucher specimen was deposited in the National Museum of Marine Biology and Aquarium, Taiwan.

3.3. Extraction and Isolation
-----------------------------

The freeze-dried and minced material of *Carijoa* sp. (wet weight 1588 g, dry weight 422 g) were extracted with a mixture of MeOH and CH~2~Cl~2~ (1:1). The extract was partitioned between EtOAc and H~2~O. The EtOAc layer was separated by silica gel and eluted using hexane/EtOAc (stepwise, 20:1--pure EtOAc) to yield 35 fractions. Fraction 17 was separated by silica gel and eluted using hexane/acetone (stepwise, 20:1--1:1) to afford **1** (1.6 mg, 2:1).

Carijoside A (**1**): white powder; mp 171--172 °C (decomp.); \[*α*\]~D~^22^-112 (*c* 0.06, CHCl~3~); IR (neat) *ν*~max~ 3466, 1743 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data, see [Table 1](#t1-marinedrugs-08-02014){ref-type="table"}; ESIMS *m/z* 717 (M + Na)^+^; HRESIMS *m/z* 717.4186 (calcd for C~38~H~62~O~11~Na, 717.4190).

3.4. Human Neutrophil Superoxide Anion Generation and Elastase Release
----------------------------------------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Superoxide anion generation was carried out according to procedures described previously \[[@b10-marinedrugs-08-02014],[@b11-marinedrugs-08-02014]\]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome *c*. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Val-*p*-nitroanilide as the elastase substrate.

3.5. Cytotoxicity Testing
-------------------------

The cytotoxicity of tested compound **1** was assayed using a modification of the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] colorimetric method. Cytotoxicity assays were carried out according to the procedures described previously \[[@b12-marinedrugs-08-02014],[@b13-marinedrugs-08-02014]\].
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###### 

^1^H and ^13^C NMR Data for Steroids **1** and **2**.

  C/H        1                                                                                 2[a](#tfn1-marinedrugs-08-02014){ref-type="table-fn"}                                                                          
  ---------- --------------------------------------------------------------------------------- ------------------------------------------------------------------ ----------------------------------------------------------- --------------
  1          1.42, m; 1.60 m                                                                   32.2 (CH~2~)                                                       1.40 m; 1.52 m                                              32.3 (CH~2~)
  2          1.86 m (2H)                                                                       28.6 (CH~2~)                                                       1.86 m                                                      30.7 (CH~2~)
  3          4.07 m                                                                            74.9 (CH)                                                          4.08 m                                                      67.6 (CH)
  4          1.69 m; 2.10 m                                                                    37.3 (CH~2~)                                                       1.63 m; 2.08 m                                              40.6 (CH~2~)
  5                                                                                            75.9 (C)                                                                                                                       76.0 (C)
  6          3.54 br s                                                                         76.0 (CH)                                                          3.52 br s                                                   75.8 (CH)
  7          1.59 m (2H)                                                                       34.6 (CH~2~)                                                       1.60 m                                                      34.3 (CH~2~)
  8          1.74 m                                                                            30.1 (CH)                                                          1.72 m                                                      30.2 (CH)
  9          1.16 m                                                                            45.9 (CH)                                                          1.25[j](#tfn10-marinedrugs-08-02014){ref-type="table-fn"}   45.7 (CH)
  10                                                                                           38.4 (C)                                                                                                                       38.2 (C)
  11         1.38 m (2H)                                                                       21.1 (CH~2~)                                                       1.37 m                                                      21.1 (CH~2~)
  12         1.16 m; 2.02 m                                                                    39.9 (CH~2~)                                                       1.16 m; 1.98 m                                              39.9 (CH~2~)
  13                                                                                           42.7 (C)                                                                                                                       42.7 (C)
  14         1.08 m                                                                            55.9 (CH)                                                          1.08 m                                                      55.9 (CH)
  15         1.08 m; 1.59 m                                                                    24.1 (CH~2~)                                                       1.08 m; 1.56 m                                              24.1 (CH~2~)
  16         1.24 m; 1.77 m                                                                    28.2 (CH~2~)                                                       1.22 m; 1.83 m                                              28.2 (CH~2~)
  17         1.10 m                                                                            56.2 (CH)                                                          1.11 m                                                      56.2 (CH)
  18         0.68 s                                                                            12.1 (CH~3~)                                                       0.67 s                                                      12.1 (CH~3~)
  19         1.20 s                                                                            17.0 (CH~3~)                                                       1.17 s                                                      17.0 (CH~3~)
  20         1.36 m                                                                            35.7 (CH)                                                          1.37 m                                                      36.0 (CH)
  21         0.90 d (6.0)[f](#tfn6-marinedrugs-08-02014){ref-type="table-fn"}                  18.7 (CH~3~)                                                       0.92 d (7.0)                                                18.6 (CH~3~)
  22         1.00 m; 1.33 m                                                                    36.0 (CH~2~)                                                       1.00 m; 1.37 m                                              35.7 (CH~2~)
  23         1.33 m (2H)                                                                       23.3 (CH~2~)                                                       1.37 m                                                      23.3 (CH~2~)
  24         1.13 m; 1.27 m[g](#tfn7-marinedrugs-08-02014){ref-type="table-fn"}                33.9 (CH~2~)                                                       1.72 m                                                      33.9 (CH~2~)
                                                                                               33.7                                                                                                                           33.7
  25         1.76 m                                                                            32.5 (CH)                                                          1.77 m                                                      32.5 (CH)
                                                                                               32.5                                                                                                                           32.4
  26a        3.82 dd (10.4, 1.6)                                                               69.6 (CH~2~)                                                       3.82 dd (2.5, 10.5)                                         69.9 (CH~2~)
             3.85 dd (10.4, 1.6)                                                               69.4                                                               3.84 dd (2.5, 10.5)                                         69.5
   b         3.92 dd (10.4, 6.0)[h](#tfn8-marinedrugs-08-02014){ref-type="table-fn"}                                                                              3.93 dd (6.0, 10.5)                                         
             3.93 dd (10.4, 6.0)[h](#tfn8-marinedrugs-08-02014){ref-type="table-fn"}                                                                              3.95 dd (6.0, 10.5)                                         
  27         0.92 d (6.8)                                                                      16.9 (CH~3~)                                                       0.90 d (6.0)                                                16.8 (CH~3~)
             0.91 d (6.8)                                                                      16.8                                                               0.91 d (6.0)                                                
  26-OAc                                                                                       171.3 (C)                                                                                                                      171.3 (C)
             2.05 s                                                                            20.9 (CH~3~)[i](#tfn9-marinedrugs-08-02014){ref-type="table-fn"}   2.05 s                                                      21.0 (CH~3~)
  1*′*       5.06 d (4.0)                                                                      97.4 (CH)                                                                                                                      
  2*′*       3.93 dd (10.4, 4.0)                                                               67.3 (CH)                                                                                                                      
  3*′*       5.13 dd (10.4, 3.2)                                                               70.5 (CH)                                                                                                                      
  4*′*       5.25 br s                                                                         69.4 (CH)                                                                                                                      
  5*′*       3.65 dd (12.8, 2.0); 3.97 m[h](#tfn8-marinedrugs-08-02014){ref-type="table-fn"}   60.9 (CH~2~)                                                                                                                   
  3*′*-OAc                                                                                     170.9 (C)                                                                                                                      
             2.07 s                                                                            21.0 (CH~3~)[i](#tfn9-marinedrugs-08-02014){ref-type="table-fn"}                                                               
  4*′*-OAc                                                                                     170.4 (C)                                                                                                                      
             2.13 s                                                                            21.0 (CH~3~)[i](#tfn9-marinedrugs-08-02014){ref-type="table-fn"}                                                               

Data was reported by Maia *et al.* \[[@b4-marinedrugs-08-02014]\];

Spectrum recorded at 400 MHz in CDCl~3~ at 25 °C;

Spectrum recorded at 100 MHz in CDCl~3~ at 25 °C;

Spectrum recorded at 500 MHz in CDCl~3~;

Spectrum recorded at 50 MHz in CDCl~3~;

*J* values (in Hz) in parentheses;

The ^1^H NMR data for these methylene protons were assigned by the assistance of Dept and HMQC spectra;

Signals overlapping;

Data exchangeable;

The coupling pattern for this methine proton was not assigned.

###### 

NMR Data for the 3*′*- and 4*′*-*O*-Acetyl-arabinopyranoside Components in Glycosides Carijoside A (**1**), Riisein A (**3**) and Riisein B (**4**).

  C/H        1                     3[a](#tfn11-marinedrugs-08-02014){ref-type="table-fn"}   4[a](#tfn11-marinedrugs-08-02014){ref-type="table-fn"}                                        
  ---------- --------------------- -------------------------------------------------------- -------------------------------------------------------- -------------- --------------------- --------------
  1*′*       5.06 d (4.0)          97.4 (CH)                                                5.04 d (4.5)                                             97.8 (CH)      5.01 d (3.5)          97.6 (CH)
  2*′*       3.93 dd (10.4, 4.0)   67.3 (CH)                                                3.94 m                                                   67.3 (CH)      3.80 dd (3.5, 10.5)   68.8 (CH)
  3*′*       5.13 dd (10.4, 3.2)   70.5 (CH)                                                5.07 dd (3.0, 9.8)                                       73.1 (CH)      3.94 m                67.8 (CH)
  4*′*       5.25 br s             69.4 (CH)                                                4.03 br s                                                68.3 (CH)      5.15 br s             71.1 (CH)
  5*′*       3.65 dd (12.8, 2.0)   60.9 (CH~2~)                                             3.66 dd (2.0, 12.5)                                      62.6 (CH~2~)   3.68 br d (11.0)      60.5 (CH~2~)
             3.97 m                                                                         3.94 m                                                                  3.93 m                
  3*′*-OAc                         170.9 (C)                                                                                                         170.9 (C)                            
             2.07 s                21.0 (CH~3~)                                             2.17 s                                                   21.2 (CH~3~)                         
  4*′*-OAc                         170.4 (C)                                                                                                                                              170.9 (C)
             2.13 s                21.0 (CH~3~)                                                                                                                     2.17 s                21.2 (CH~3~)

Data was reported by Maia *et al.* \[[@b4-marinedrugs-08-02014]\].
